gptkbp:instance_of
|
gptkb:virus
|
gptkbp:affects
|
respiratory system
|
gptkbp:case_types
|
millions
|
gptkbp:casualties
|
millions
|
gptkbp:caused_by
|
gptkb:COVID-19
|
gptkbp:discovered_by
|
gptkb:2019
|
gptkbp:family
|
gptkb:virus
|
gptkbp:genetic_diversity
|
high
|
gptkbp:genus
|
gptkb:Betacoronavirus
|
gptkbp:healthcare
|
gptkb:quarantine_measures
lockdowns
travel restrictions
|
https://www.w3.org/2000/01/rdf-schema#label
|
alpha coronavirus
|
gptkbp:impact
|
mental health
global economy
education systems
healthcare systems
|
gptkbp:is_monitored_by
|
genomic sequencing
contact tracing
serological surveys
|
gptkbp:is_protected_by
|
mask wearing
hand hygiene
social distancing
|
gptkbp:is_recognized_by
|
gptkb:Wuhan,_China
|
gptkbp:is_vulnerable_to
|
gptkb:battle
|
gptkbp:provides_information_on
|
public awareness campaigns
mask mandates
vaccination campaigns
testing availability
|
gptkbp:research_focus
|
vaccine development
long COVID
treatment options
viral mutations
transmission dynamics
|
gptkbp:risk_factor
|
age
obesity
underlying health conditions
|
gptkbp:scientific_classification
|
gptkb:healthcare_organization
gptkb:Public_Health_Emergency_of_International_Concern
|
gptkbp:seed_dispersal
|
approximately 30 kb
|
gptkbp:social_responsibility
|
PCR test
|
gptkbp:symptoms
|
cough
fever
shortness of breath
|
gptkbp:transmission
|
human-to-human
|
gptkbp:treatment
|
supportive care
monoclonal antibodies
antiviral drugs
immunomodulators
convalescent plasma
|
gptkbp:variant
|
gptkb:Alpha_variant
gptkb:Delta_variant
gptkb:SARS-Co_V-2
gptkb:Gamma_variant
Omicron variant
Beta variant
|
gptkbp:bfsParent
|
gptkb:Gammacoronavirus
|
gptkbp:bfsLayer
|
5
|